• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,755.05 -715.06
( -0.92%)
Global Indices
Nasdaq
52,250.80 5.16
(0.01%)
Dow Jones
7,521.33 -8.87
(-0.12%)
Hang Seng
66,164.55 -67.64
(-0.10%)
Nikkei 225
10,722.03 136.12
(1.29%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

EQUITY - MARKET SCREENER

Mahindra & Mahindra Ltd
Industry :  Automobiles - Passenger Cars
BSE Code
ISIN Demat
Book Value()
500520
INE101A01026
597.8623299
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
M&M
25.12
394776.88
EPS(TTM)
Face Value()
Div & Yield %
126.39
5
1
 

shree maa agri industries ltd
USFDA inspects Cipla subsidiary's manufacturing unit in New York
Jul 18,2026

Cipla announced that an inspection was conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of InvaGen Pharmaceuticals Inc. (wholly owned subsidiary of the company) located in Central Islip, Long Island, New York, USA, from 13 July 2026 to 17 July 2026 (EDT).

The inspection was a routine current Good Manufacturing Practices (cGMP) Inspection. On conclusion of the inspection, the company has received 1 (one) inspectional observation in Form 483.